糸魚川・地域医療支援学講座

Keyphrases

1. Left Ventricular Noncompaction 100%
2. Type 2 Diabetes Mellitus (T2DM) 54%
3. Kawasaki Disease 52%
4. Japanese Population 36%
5. 3T3-L1 Adipocytes 34%
6. Single nucleotide Polymorphism 28%
7. Insulin 25%
8. Insulin Receptor Substrate 1 (IRS1) 23%
9. Hypertrophic Cardiomyopathy 22%
10. Japan 20%
11. Insulin Resistance 20%
12. Insulin Receptor 18%
13. Advanced Gastric Cancer 18%
14. Congenital Heart Disease 18%
15. Insulin Signaling 17%
16. Cardiomyopathy 16%
17. Japanese Patients 15%
18. Meta-analysis 15%
19. Replication Study 15%
20. Dilated Cardiomyopathy 15%
21. Genome-wide Association Study 14%
22. Tumor Necrosis Factor-α 14%
23. Pediatric Patients 14%
24. Next-generation Sequencing 14%
25. Systematic Meta-analysis 14%
26. Interleukin-1β 14%
27. Single Ventricle Physiology 13%
28. Genetic Variants 12%
29. Heart Failure 12%
30. Pioglitazone 12%
31. Nivolumab 12%
32. Japanese children 12%
33. Warfarin 12%
34. MYH7 11%
35. Phosphoinositide 3-kinase (PI3K) 11%
36. Clinical Significance 10%
37. Fibroblasts 10%
38. Stomach 10%
39. Gene Variants 10%
40. Pathogenic Variants 10%
41. Fetal Onset 9%
42. Type 2 Diabetic Patients 9%
43. Glucose Uptake 9%
44. Suppressor of Cytokine Signaling 3 (SOCS3) 9%
45. Heat Shock Protein 90 (Hsp90) 9%
46. Gastrointestinal Stromal Tumor 9%
47. Neurodevelopmental Outcome 9%
48. Orai1 9%
49. Novel Variation 9%
50. Tadalafil 9%
51. Dose-response Relationship 9%
52. Sildenafil 9%
53. Intestinal Absorption 9%
54. Confidence Interval 9%
55. Coronary Artery Lesions 9%
56. Left Ventricular Function 9%
57. Congestive Heart Failure 8%
58. Sudden Death 8%
59. Proband 8%
60. Bosentan 8%
61. Arrhythmia 8%
62. Fasting Plasma Glucose 8%
63. Tyrosine Phosphorylation 8%
64. Inherited Cardiomyopathy 7%
65. Heterozygous Variant 7%
66. Odds Ratio 7%
67. Genetic Risk Score 7%
68. Chronic Heart Failure 7%
69. Genotype-phenotype Correlation 7%
70. Autopsy 7%
71. Diabetes 7%
72. Papilla of Vater 7%
73. Ramucirumab 7%
74. 3-year-olds 7%
75. Myopathy 7%
76. Trabeculation 7%
77. Genetic Background 6%
78. Pediatric 6%
79. Mitogenesis 6%
80. Allergic Diseases 6%
81. Congenitally Corrected Transposition of the Great Arteries (ccTGA) 6%
82. MYH7 Gene 6%
83. Neonate 6%
84. Single Ventricle 6%
85. School Age 6%
86. Interleukin-6 6%
87. Sarcomere Genes 6%
88. Jejunum 6%
89. Serum Levels 6%
90. Nationwide Survey 6%
91. Gastric Cancer 6%
92. Hemoglobin A1c (HbA1c) 6%
93. Phosphorylation 6%
94. Thiazolidinedione Derivatives 6%
95. Tyrosine 6%
96. Developmental Delay 6%
97. Gene mutation 6%
98. Anticoagulant Effect 5%
99. Japanese Family 5%
100. Clinical Trials 5%

Medicine and Dentistry

1. Noncompaction Cardiomyopathy 76%
2. Maturity Onset Diabetes of the Young 28%
3. Persistent Truncus Arteriosus 25%
4. Congestive Heart Failure 21%
5. Myocardial Disease 19%
6. Abdominal Cancer 16%
7. Coronary Artery 14%
8. Heart Single Ventricle 14%
9. Patient with Kawasaki Disease 13%
10. MYH7 12%
11. Single Nucleotide Polymorphism 12%
12. Next Generation Sequencing 12%
13. Nivolumab 12%
14. Kawasaki Disease 11%
15. Disease 10%
16. Pediatrics 10%
17. Electrocardiogram 10%
18. Dilated Cardiomyopathy 9%
19. Genome Wide Association Study 9%
20. Pediatrics Patient 9%
21. Sarcomere 8%
22. Hypertrophic Cardiomyopathy 8%
23. Neoplasm 7%
24. Infancy 7%
25. Cardiac Dysrhythmia 7%
26. Coronary Artery Aneurysm 7%
27. Multidetector Computed Tomography 7%
28. Reoperation 7%
29. Sudden Unexpected Death in Epilepsy 7%
30. Brain Natriuretic Peptide 6%
31. Hemodynamic 6%
32. Immunoglobulin 6%
33. Great Arteries 6%
34. Echocardiography 6%
35. Allele 6%
36. Jejunum 6%
37. Neonate 6%
38. Thromboembolism 6%
39. Amino Terminal Sequence 6%
40. Extracorporeal Circulation 6%
41. Right Coronary Artery 5%
42. Prevalence 5%
43. Endothelial Cell 5%
44. Ventricular Septal Defect 5%
45. Overall Survival 5%
46. Genetic Risk 5%
47. Immune-Related Adverse Events 5%
48. Genotype Phenotype Correlation 5%